FindTrial
Sign In

Development and application of early screening and diagnosis technology for postpartum depression based on gut-brain axis multiomics

Development and application of early screening and diagnosis technology for postpartum depression based on gut-brain axis multiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100694
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum depression

Interventions

Observation group:None

Sponsors

Obstetrics and Gynecology Hospital Affiliated to Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.12-14 weeks of gestation, 2.Those who agree to voluntarily and actively cooperate and sign the consent letter.

Exclusion criteria

Exclusion criteria: 1.Use of antipsychotics by a history of mental illness or within the last three months; 2.Long-term smoking or drinking; 3.Type 1 or type 2 diabetes who have been diagnosed before pregnancy; 4.Gestational hypertension, diabetic ketoacidosis, thyroid dysfunction or infection; 5.Heart, liver, kidney and other important organ diseases; 6.Definite digestive diseases; 7.Unable to complete the study, with mental or cognitive disabilities; 8.Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Postpartum depression;—

Countries

China

Contacts

Public ContactXinzhong Chen

Obstetrics and Gynecology Hospital Affiliated to Zhejiang University School of Medicine

Chenxinz@zju.edu.cn+86 135 7573 8058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026